Complication of diabetes Flashcards

1
Q

DKA vs HHS (hyperosmolar hyperglycemic state)
Who is it more common in

A

DKA
- common in young people with type 1

HHS
- adult or elder with type 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

DKA vs HHS
Glucose levels?

A

DKA
- normal-high glucose
- 14+ (or sometimes lower)

HHS
- Higher glucose >22

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

DKA vs HHS
Symptoms?

A

DKA
- SOME reduced level of consciousness, hypokalemia, kussmal breathing, fruity breath

HHS
- SEVERELY reduced level of consioussness, hypokalemia
NO kussmal breathing or fruity breath, or positive urine acetone test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

DKA vs HHS
onset/mortality

A

DKA
- Fast onset
- Lower mortality rate

HHS
- Slow onset
- Higher mortality rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

DKA vs HHS
pathophysiology

A

DKA
- Absolute insulin deficiency
- increased glucagon
- milder hyperosmolarity

HHS
- relative insulin deficiency
- no ketones present
- minimal acid-base problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

DKA vs HHS
Treatment

A

DKA
- MUST use insulin
- IV fluids, Serum K+, Insulin

HHS
- MAY use insulin
- Hydration, Serum K+, +/- insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are common features of DKA vs HHS

A

Insulin deficiency –> hyperglycemia –> urinary loss of water + electrolytes
- volume depletion + electrolyte + hyperosmolarity

Both will be fluid depleted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Is it possible that a patient with no diabetes get HHS?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which groups of people should you assess for DKA if symptoms are present but BG is not elevated

A

Pregnancy & SGLT2 use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What specific test should be ordered to identify DKA and ketones in the blood?

A

B-hydroxy butyrate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are conditions that can make DKA diagnosis difficult (3)

A
  1. Conditions that inc bicarb (eg. vomiting)
  2. Significant osmotic diuresis –> loss of keto anions = normal anion gap
  3. Pregnancy and SGLT2i –> mildly inc glucose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are common causes/precipitating factors of DKA

A
  • Insulin omission
  • New diagnosis of diabetes
  • infection/sepsis
  • MI
  • Thyrotoxicosis
  • Drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How to prevent DKA in type 1 and type 2 diabetes

A

Type 1
- education around sick day management
- continuation of insulin EVEN when not eating (dose may need adjustment)
- frequent monitoring when ill

Type 2
- education around sick day management
- Frequent monitoring when ill

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SADMANS acronym

A

Solfunylurea
ACEi
Diuretics
Metformin
ARB
NSAIDs
SGLT2i

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How often should you check blood or urine ketones and BG when you’re sick?

A

Every 2-4 hours

or if symptoms of DKA are experienced (

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When should you seek your primary care provider or emergency when you’re sick with diabetes?

A
  • If vomiting occurs twice or more within 12 hours
  • on going diarrhea or getting worse
  • or when symptoms of DKA are experienced (nausea, vomiting or abdominal pain)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

If you cannot tolerate solid food when you are sick how much CHO should you aim for?

A

15g of CHO every hour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Define microvascular, macrovascular and mixed complications

A

Microvascular: small BV
- Retinopathy
- Nephropathy
- Neuropathy

Macrovascular: large BV
- Atherosclerosis
- lipid abnormalities
- CHD coronary heart disease
- Cerebrovascular and peripheral vascular disease CVD and PVD
- hypertension
- Heart failure

Mixed complications
- combination of micro and macro and/or neuropathic changes
ex. foot problems and ED can be both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are symptoms of retinopathy?
Both eyes or one eye affected?

A
  • Seeing spots or floaters
  • Blurred vision
  • Having a dark/empty/black spots in the center of vision
  • Difficulty seeing well at night
  • Noticing colours appear faded or washed out losing vision

Both eyes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the 4 forms of retinopathy. Define them

A
  1. Macular edema
    - diffuse or focal vascular leakage at the macula
  2. Non-proliferative
    - Microaneurysms, intraretinal hemmorage, vascular tortuosity, and vascular malformation
    - Damaged BV leak fluids and fat into the retina
  3. Proliferative
    - abnormal vessel growth
    - BV to retina therefore retina produces new abnormal BV
  4. Retinal Capillary close
    - Limited profusion
21
Q

Most common cause of blindness among working age
in type 1
Type 2 on insulin
Type 2 not on insulin

A

Type 1:
- proliferative retinopathy

Type 2 insulin
- Macular edema

Type not on insulin
- Macular edema
- not as prevalent though

22
Q

When to initiate screening for retinopathy in type 1 and 2

A

Type 1: 5 years after diagnosis if 15+

Type 2: everyone at diagnosis

23
Q

How to prevent/delay getting retinopathy (3)

A
  1. Glycemic control: A1C 7 or under
  2. BP control: less than 130/80
  3. Lipid-lowering therapy: Fibrates
24
Q

Can retinopathy be treated? How?

A

Yes

Laser therapy (reduce blindness by 90% in non/proliferative retinopathy)
VEGF antagonists (pharmacologic options)
Surgery (removing vitreous humor)

25
How to diagnose CKD?
ACR (albumin-creatine ratio) 2.0 mg/mmol+ and/or eGFR <60 rescreen in 1 year
26
Define nephorpathy. What is the first/best marker for this condition?
Nephropathy - increase in proteinuria in people with longstanding diabetes, followed by declining function which can lead to end-stage First/best marker = microalbuminuria
27
What is the range for normal, microalbuminuria, overt nephropathy on a urine dipstick. (negative/positive)
Normal (negative) - ACR under 2 Microalbuminuria (negative) - ACR 2-20 Overt nephropathy/ macroalbuminuria (postive) - ACR over 20
28
What are potential causes of transient albuminuria/ when should you delay treatment?
Recent major exercise UTI Fever illness Decompensated CHF Menstruation Acute severe elevation in BG/BP
29
What is first line drug therapy for CKD and diabetes? in type 1 and type 2
Type 2: - SGLT2i if eGFR over 20 - Metformin if eGFR 30+ Type 1 and 2: - ACE/ARB if htn - Statin
30
Differentiate between glycemic control in micro vs macro albuminuria
Microalbuminuria - intensive therapy (lowering A1C target) can bring you back to normal levels Macro - intensive therapy can prevent progression to CKD (not as much benefit)
31
How to prevent progression of diabetic nephropathy?
- optimal glycemic control - optimal BP control - ACEi/ARB - SGLT2i - Non-steroidal MRA if ACR over 3 (finerenone)
32
Can you use ACEi and ARB to slow progression of nephropathy even in the absence of hypertension?
Yes
33
What will you expect with Cr when you start ACEi/ARB?
Can go up to 30% in the beginning Ok for renal function to go down a bit
34
What does neuropathy cause you to have an increased risk for?
- Foot ulceration and amputation - Neuropathic pain - Significant morbidity - Usage of healthcare resources
35
What are risk factors for neuropathy
- Elevated BG - elevated Triglycerides - High BMI - Smoking - Hypertesnion
36
What are autonomic neuropathies that can effect other biologic systems
1. GI - gastroparesis, constipation, diarrhea, esophageal dysmotility 2. CV neuropathy - exercise intolerance, postural hypotension, tachycardio 3. Genitourinary - incontinence, ED, female sexual dysfunction Sudomotor - sweating dysfunction, heat intolerance, dry skin Pupillary - pupil abnormalities Metabolic - hypoglycemia unawareness and unresponsiveness
37
Give 2 examples of screening for diabetic neuropathy
1. 10g semmes-weinstein monofilament - gauges the patients ability to perceive the sensation of a metal filament touching their big toe 2. 128Hz vibration tuning fork - testing if they can sense vibration on the bone of their toe for 40 seconds
38
What is first line, second line, and other options for treatment for neuropathic pain
First line - anticonvulsants - antidepressants 2nd line - opioids Other - topical nitrate - capsaicin - transcutaneous electrical nerve stimulation
39
What is the best anticonvulsant used for neuropathic pain approved? Other?
Pregablin (needs renal adjustment) Other: - gabapentin - valproate
40
What is the best antidepressant used for neuropathic pain approved? Other?
Duloxetine Other - amitriptyline - venlafaxine
41
Do people get full relief of neuropathy pain?
Yes, only a few people have complete relief A 30-50% reduction in pain is considered meaningful (hard to get complete relief)
42
Which method of CVD prevention was better in type 2 diabetes, intensive vs. conventional? What does it entail?
Intensive (BETTER) - therapies to achieve targets in glycemia, lipids, BP, albuminuria - follow-up q3months - ASA and ACEi (independant of BP) Conventional arm - follow clinical practice guidelines
43
Who should recieve statins (regardless of baseline LDL) (4)
- Clinical CVD - Age 40+ - Microvascular complications - Diabetes for over 15 years and age 30+
44
Who shouldn't be on a statin or ACE/ARB?
Women who are pregnant or trying to be.
45
Who should recieve ACEi/ARB therapy regardless of baseline BP? (3)
- Clinical CVD - Age 55+ with a CV Risk factor or end organ damage (albuminuria, retinopathy) - Microvascular complications
46
Which drugs help in reduction in MACE (major adverse cardio events)
SGLT2i GLP1-RA
47
Which drugs reduce hospitalization for heart failure
SGLT2i
48
Which drugs increase risk of hospitalization for heart failure
TZDs Saxagliptin
49
When should ASA be used in diabetes
For secondary prevention of CVD events No overall benefit for primary prevention - bleed risk outweighs benefits